Most MS treatments don't increase the risk for miscarriage or major birth defects when used during pregnancy, an analysis ...

Many people living with the degenerative neurological disease multiple sclerosis (MS) are premenopausal women. This means ...

If you have multiple sclerosis (MS) and are hoping to get pregnant, the news is good: MS itself does not make a pregnancy ...

多发性硬化（multiple sclerosis，MS）是一种免疫介导的中枢神经系统（central nervous system，CNS）炎性脱髓鞘疾病，其病变具有时间多发（dissemination in ...

ANK-700 is under clinical development by Anokion and currently in Phase I for Relapsing Remitting Multiple Sclerosis (RRMS).

An investigational drug for multiple sclerosis from Io Therapeutics has restored leg mobility and myelin nerve coatings in ...

MS patients show large differences between vascular age and chronological age, even if they don't have cardiovascular disease ...

Multiple sclerosis (MS) is a demyelinating neurological condition. “Demyelinating” means the loss of the protective sheath around nerves in your central nervous system. It can cause many ...

Research published on 20th December, 2024 could help neurologists in the future prescribe personalised treatment to people living with multiple sclerosis (MS), after scientists studied more than half ...

MP-1032 is under clinical development by MetrioPharm and currently in Phase I for Multiple Sclerosis. According to GlobalData, Phase I drugs for Multiple Sclerosis have a 72% phase transition success ...

Analysis of Biogen's stock performance in 2024, focusing on sales struggles, financial health, and valuation. Read more here.